| 1 |
Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond[J]. Blood, 2013, 122(4): 491-498.
|
| 2 |
Forman SJ, Negrin RS, Antin JH, et al. Thomas' hematopoietic cell transplantation: Stem cell transplantation, fifth edition[M]. Oxford, England: John Wiley & Sons, Ltd, 2015:437-455.
|
| 3 |
杨曦, 赵晓东. 原发性免疫缺陷病分类(2017伦敦版)解读[J]. 中华儿科杂志, 2018, 56(9):648-650.
|
| 4 |
Pai SY, Logan BR, Griffith LM, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009[J]. N Engl J Med, 2014, 371(5):434-446.
|
| 5 |
Gaspar HB, Qasim W, Davies EG, et al. How I treat severe combined immunodeficiency[J]. Blood, 2013, 122(23):3749-3758.
|
| 6 |
Fernandes JF, Rocha V, Labopin M, et al. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?[J]. Blood, 2012, 119(12):2949-2955.
|
| 7 |
Morio T, Atsuta Y, Tomizawa D, et al. Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan[J]. Br J Haematol, 2011, 154(3):363-372.
|
| 8 |
Díaz De Heredia C, Ortega JJ, Díaz MA, et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies[J]. Bone Marrow Transplant, 2008, 41(7):627-633.
|
| 9 |
Cole T, Pearce MS, Cant AJ, et al. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation[J]. J Allergy Clin Immunol, 2013, 132(5):1150-1155.
|
| 10 |
Tewari P, Martin PL, Mendizabal A, et al. Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high Long-Term donor chimerism and excellent survival in chronic granulomatous disease[J]. Biol Blood Marrow Transplant, 2012, 18(9):1368-1377.
|
| 11 |
Gozdzik J, Pituch-Noworolska A, Skoczen SA, et al. Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous Disease-Single centre experience[J]. J Clin Immunol, 2011, 31(3):332-337.
|
| 12 |
Jaing TH, Lee WI, Cheng PJ, et al. Successful unrelated donor cord blood transplantation for chronic granulomatous disease[J]. Int J Hematol, 2010, 91(4):670-672.
|
| 13 |
Lin CJ, Wang SC, Ku CL, et al. Successful unrelated cord blood stem cell transplantation in an x-linked chronic granulomatous disease patient with disseminated BCG-induced infection[J]. Pediatr Neonatol, 2015, 56(5):346-350.
|
| 14 |
Soncini E, Slatter MA, Jones LB, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth[J]. Br J Haematol, 2009, 145(1):73-83.
|
| 15 |
Al-Dhekri H, Al-Mousa H, Ayas M, et al. Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience[J]. Biol Blood Marrow Transplant, 2011, 17(8):1245-1249.
|
| 16 |
Sakaguchi H, Nakanishi K, Kojima S. Inherited bone marrow failure syndromes in 2012[J]. Int J Hematol, 2013, 97(1):20-29.
|
| 17 |
Macmillan ML, Wagner JE. Haematopoeitic cell transplantation for Fanconi anaemia-when and how?[J]. Br J Haematol, 2010, 149(1):14-21.
|
| 18 |
de la Fuente J, Dokal I. Dyskeratosis congenita:advances in the understanding of the telomerase defect and the role of stem cell transplantation[J]. Pediatr Transplant, 2007, 11(6):584-594.
|
| 19 |
Dietz AC, Orchard PJ, Baker KS, et al. Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita[J]. Bone Marrow Transplant, 2011, 46(1):98-104.
|
| 20 |
De Latour RP. Transplantation for bone marrow failure: current issues[J]. Hematology Am Soc Hematol Educ Program, 2016 (1):90-98.
|
| 21 |
Broxmeyer HE. Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation[J]. Transfus Apher Sci, 2016, 54(3):364-372.
|
| 22 |
Gluckman E, Rocha V, Ionescu I, et al. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival[J]. Biol Blood Marrow Transplant, 2007, 13(9):1073-1082.
|
| 23 |
Buchbinder D, Hsieh L, Mahajerin A, et al. Successful treatment of secondary graft failure following unrelated cord blood transplant with hematopoietic growth factors in a pediatric patient with Fanconi anemia[J]. Pediatr Transplant, 2015, 19(7):E181-E184.
|
| 24 |
Jaing TH, Chen SH, Yang CP, et al. Successful hematopoietic reconstitution by unrelated donor cord blood transplantation in children with fanconi anemia: report of 3 cases[J]. J Pediatr Hematol Oncol, 2014, 36(8):E553-E555.
|
| 25 |
Prasad VK, Kurtzberg J. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions[J]. Br J Haematol, 2010, 148(3):356-372.
|
| 26 |
Prasad VK, Kurtzberg J. Transplant outcomes in mucopolysaccharidoses[J]. Semin Hematol, 2010, 47(1):59-69.
|
| 27 |
Boelens JJ, Aldenhoven M, Purtill D, et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning[J]. Blood, 2013, 121(19):3981-3987.
|
| 28 |
Boelens JJ, Rocha V, Aldenhoven M, et al. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome[J]. Biol Blood Marrow Transplant, 2009, 15(5):618-625.
|
| 29 |
Aldenhoven M, Jones SA, Bonney D, et al. Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines[J]. Biol Blood Marrow Transplant, 2015, 21(6):1106-1109.
|
| 30 |
Boelens JJ, Wynn RF, O'Meara A, et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe:a risk factor analysis for graft failure[J]. Bone Marrow Transplant, 2007, 40(3):225-233.
|
| 31 |
Miller WP, Rothman SM, Nascene D, et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report[J]. Blood, 2011, 118(7):1971-1978.
|
| 32 |
Prasad VK, Mendizabal A, Parikh SH, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes[J]. Blood, 2008, 112(7):2979-2989.
|
| 33 |
Van Den Broek B, Page K, Paviglianiti A, et al. Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies[J]. Blood Adv, 2018, 2(1):49-60.
|
| 34 |
Engelen M, Kemp S, Poll-The BT. X-linked adrenoleukodystrophy: pathogenesis and treatment[J]. Curr Neurol Neurosci Rep, 2014, 14(10):486.
|
| 35 |
Beltran-Quintero ML, Bascou NA, Poe MD, et al. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months[J]. Orphanet J Rare Dis, 2019, 14(1):46.
|
| 36 |
Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease[J]. N Engl J Med, 2005, 352(20):2069-2081.
|
| 37 |
Anna, Monica, Bianco, et al. Genetics of inflammatory bowel disease from multifactorial to monogenic forms[J]. World J Gastroenterol, 2015, 21(43):12296-12310.
|
| 38 |
Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy[J]. Gastroenterology, 2012, 143(2):347-355.
|
| 39 |
Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10-and IL-10 receptor–deficient patients with or without hematopoietic stem cell transplantation[J]. J Allergy Clin Immunol, 2013, 131(3):825-830.
|
| 40 |
Pigneur B, Escher J, Elawad M, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the GENIUS working group[J]. Inflamm Bowel Dis, 2013, 19(13):2820-2828.
|
| 41 |
Huang Z, Peng K, Li X, et al. Mutations in interleukin-10 receptor and clinical phenotypes in patients with very early onset inflammatory bowel disease[J]. I Inflamm Bowel Dis, 2017, 23(4):578-590
|